Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuroscience
Research
NIH leader's research misconduct calls drugs into question
One of the drugs facing new questions is prasinezumab, an antibody for Parkinson’s disease being developed by Prothena Biosciences and Roche.
Darren Incorvaia
Sep 26, 2024 9:12am
The neural circuits behind the placebo effect
Jul 24, 2024 9:02am
J&J's oral add-on aces phase 3 in major depressive disorder
May 29, 2024 11:55am
Takeda gets crafty with molecular glue deal worth $1.2B biobucks
May 23, 2024 5:30am
Third Rock, J&J neuroscience spinout Rapport outlines IPO plans
May 20, 2024 5:13am
GE HealthCare debuts dedicated head-only MRI scanner
May 7, 2024 5:47pm